Catalyst
Slingshot members are tracking this event:
Bayer Receives FDA Approval for Kovaltry for the Treatment of Children and Adults with Hemophilia A
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
BAYN.SW |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 17, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Antihemophilic Factor Viii, Recombinant, Leopold Clinical Trials, Hemophilia A, Prophylaxis